Contract Pharma Conclusion
In September, Todd Bokus and I attended the 2022 Contract Pharma Contracting & Outsourcing Conference, a prominent event in the Pharma Services space. Below are our key takeaways from the event:
Event Attendance
We were pleased to see such a strong turnout for this event by both exhibitors and attendees. A few individuals even mentioned that we seemed to have returned to “pre-COVID levels” in terms of attendance at this conference in particular. Contract Pharma was well-attended not only by industry leaders, but also by Private Equity firms in our close network, exhibiting a sustained strong demand for investment in the space. Leaders and top innovators in the Outsourced Pharma industry were all in attendance as well, including leaders in lab services, research and development, clinical trial services, manufacturing, regulatory consulting, data analytics, commercialization services, and more.
Trends
During our discussions at the conference, we observed several industry trends worth noting.
领英推荐
Conclusion
Contract Pharma held a successful event with fantastic turnout, and we thoroughly enjoyed the opportunity to connect with leaders in our network and continue to build valuable relationships with others in the industry.
Upcoming Conferences
Bourne Partners will be attending all major upcoming industry conferences and looks forward to meeting with management teams in attendance to continue the dialogue. See our events page for details and contact information.